Published in JAMA on May 14, 1997
The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects. J Am Acad Dermatol (2012) 1.79
A polymorphism in the agouti signaling protein gene is associated with human pigmentation. Am J Hum Genet (2002) 1.63
Melanoma genetics and the development of rational therapeutics. J Clin Invest (2005) 1.50
Melanoma survival in the United States, 1992 to 2005. J Am Acad Dermatol (2011) 1.44
A place in the shade: reducing the risks of UV exposure. CMAJ (1997) 1.40
The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia. Annu Rev Pathol (2014) 1.22
Melanoma epidemiology. Hematol Oncol Clin North Am (2009) 1.21
Study of Nevi in Children (SONIC): baseline findings and predictors of nevus count. Am J Epidemiol (2008) 1.21
Combined risk factors for melanoma in a Mediterranean population. Br J Cancer (2001) 1.06
Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants. J Med Genet (2013) 1.04
Low rates of clinical recurrence after biopsy of benign to moderately dysplastic melanocytic nevi. J Am Acad Dermatol (2009) 1.03
Dysplastic nevi and melanoma. Cancer Epidemiol Biomarkers Prev (2013) 0.98
Telomerase activity in melanocytic lesions: A potential marker of tumor biology. Am J Pathol (2000) 0.97
The dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical management. J Am Acad Dermatol (2012) 0.96
Strategies for early melanoma detection: Approaches to the patient with nevi. J Am Acad Dermatol (2009) 0.93
Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking? Lab Invest (2013) 0.92
Sunbeds and sunlamps: who used them and their risk for melanoma. Pigment Cell Melanoma Res (2011) 0.92
Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues. J Clin Pathol (2005) 0.90
Overexpression of Chromatin Assembly Factor-1/p60 helps to predict the prognosis of melanoma patients. BMC Cancer (2010) 0.90
Cutaneous Melanoma in Asians. Chonnam Med J (2016) 0.86
From melanocytes to melanomas. Nat Rev Cancer (2016) 0.85
Factors associated with inconsistent sun protection in first-degree relatives of melanoma survivors. Qual Health Res (2012) 0.83
Cigarette smoking and malignant melanoma: a case-control study. J Am Acad Dermatol (2010) 0.82
XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk. Br J Cancer (2004) 0.82
Resveratrol modulates the malignant properties of cutaneous melanoma through changes in the activation and attenuation of the antiapoptotic protooncogenic protein Akt/PKB. Melanoma Res (2011) 0.82
A melanoma risk score in a Brazilian population. An Bras Dermatol (2013) 0.80
Screening strategies for cancer. Implications and results. JAMA (1997) 0.79
Development of a melanoma risk prediction model incorporating MC1R genotype and indoor tanning exposure: impact of mole phenotype on model performance. PLoS One (2014) 0.79
On the clinical significance of cutaneous melanoma's precursors. Indian Dermatol Online J (2012) 0.79
Association of genetic variants in CDK6 and XRCC1 with the risk of dysplastic nevi in melanoma-prone families. J Invest Dermatol (2013) 0.78
Current Data on Risk Factor Estimates Does Not Explain the Difference in Rates of Melanoma between Hispanics and Non-Hispanic Whites. J Skin Cancer (2016) 0.78
Prevalence and predictors of recent skin examination in a population-based twin cohort. Cancer Epidemiol Biomarkers Prev (2015) 0.77
"Better do not touch" and other superstitions concerning melanoma: the cross-sectional web-based survey. Postepy Dermatol Alergol (2016) 0.75
Differentiating dysplastic nevi from melanoma. JAMA (1997) 0.75
Correlation between dermoscopic and histopathological diagnoses of atypical nevi in a dermatology outpatient clinic of the Medical School of São José do Rio Preto, SP, Brazil. An Bras Dermatol (2013) 0.75
Histopathological characteristics of small diameter melanocytic naevi. J Clin Pathol (2003) 0.75
Melanocytic Nevi and the Genetic and Epigenetic Control of Oncogene-Induced Senescence. Dermatol Clin (2017) 0.75
Naevus-associated lentigo maligna: coincidence or continuum? Hippokratia (2011) 0.75
Living a "shady life": sun-protective behaviour for Canadians. CMAJ (1999) 0.75
Incidence of atypical nevi in Olmsted County: an epidemiological study. J Cutan Pathol (2016) 0.75
Various Dermatoses What the Patients with Cutaneous Melanoma Had Anxiety for the Recurrence during Postoperative Surveillance. Ann Dermatol (2017) 0.75
Tumors of the hand. Eur J Orthop Surg Traumatol (2017) 0.75
The sequence of the human genome. Science (2001) 101.55
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med (1997) 13.96
The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res (1969) 13.27
Germline p16 mutations in familial melanoma. Nat Genet (1994) 5.59
Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials (2000) 5.37
Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst (1989) 5.28
Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression. Cancer Res (1990) 4.22
Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. N Engl J Med (1995) 4.10
Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet (1998) 3.61
THE CLINICAL EVALUATION OF AUREOMYCIN. J Clin Invest (1949) 3.60
Validation studies using an alloyed gold standard. Am J Epidemiol (1993) 3.56
A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol (1984) 3.21
Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. N Engl J Med (1989) 3.03
Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis (1998) 2.82
Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome'. Arch Dermatol (1978) 2.81
Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst (2001) 2.73
The classification of malignant melanoma and its histologic reporting. Cancer (1973) 2.67
Random digit dialing in selecting a population-based control group. Am J Epidemiol (1984) 2.64
The C8/144B monoclonal antibody recognizes cytokeratin 15 and defines the location of human hair follicle stem cells. J Cell Sci (1998) 2.58
Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome. N Engl J Med (1985) 2.54
A practice counsellor. J R Coll Gen Pract (1978) 2.47
Attributable risk: advantages of a broad definition of exposure. Am J Epidemiol (1994) 2.45
E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am J Pathol (2000) 2.36
Common and uncommon melanocytic nevi and borderline melanomas. Semin Oncol (1975) 2.36
The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews. Nat Genet (1998) 2.32
Human melanoma progression in skin reconstructs : biological significance of bFGF. Am J Pathol (2000) 2.23
CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations. Oncogene (2008) 2.19
Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J Infect Dis (2000) 2.16
Non-differential misclassification and bias towards the null: a clarification. Occup Environ Med (1995) 2.15
Vascular involvement in the prognosis of primary cutaneous melanoma. Arch Dermatol (2001) 2.12
Melanoma cell lines from different stages of progression and their biological and molecular analyses. Melanoma Res (1997) 2.11
Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation. N Engl J Med (2001) 2.11
Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma. Cancer (1980) 2.04
Human hair follicle bulge cells are biochemically distinct and possess an epithelial stem cell phenotype. J Investig Dermatol Symp Proc (1999) 1.96
Survival and quality of life among patients receiving unproven as compared with conventional cancer therapy. N Engl J Med (1991) 1.95
The developmental biology of primary human malignant melanomas. Semin Oncol (1975) 1.92
Premarital sex, schoolgirl pregnancy, and school quality in rural Kenya. Stud Fam Plann (2001) 1.91
Optimal resection margin for cutaneous malignant melanoma. Plast Reconstr Surg (1983) 1.89
Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Res (1985) 1.85
Temporal trends in the incidence of non-Hodgkin's lymphoma and selected malignancies in a population with a high incidence of acquired immunodeficiency syndrome (AIDS) Am J Epidemiol (1988) 1.80
High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. AIDS (1998) 1.79
Bladder cancer, drinking water source, and tap water consumption: a case-control study. J Natl Cancer Inst (1987) 1.77
Precursor lesions in familial melanoma. A new genetic preneoplastic syndrome. JAMA (1978) 1.74
Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies. Proc Natl Acad Sci U S A (1984) 1.74
Incidence of sentinel node metastasis in patients with thin primary melanoma (< or = 1 mm) with vertical growth phase. Ann Surg Oncol (2000) 1.74
Extraadrenal myelolipoma: MR imaging findings. AJR Am J Roentgenol (1998) 1.73
Familial cutaneous malignant melanoma: autosomal dominant trait possibly linked to the Rh locus. Proc Natl Acad Sci U S A (1983) 1.72
Urinary tract infection and risk of bladder cancer. Am J Epidemiol (1984) 1.70
Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. The International Melanoma Analysis Group (IMAGE). Int J Cancer (1995) 1.68
Lentigo maligna and lentigo-maligna melanoma. Am J Pathol (1969) 1.68
The clinical diagnosis, classification and histogenetic concepts of the early stages of cutaneous malignant melanomas. N Engl J Med (1971) 1.65
A multiobserver, population-based analysis of histologic dysplasia in melanocytic nevi. J Am Acad Dermatol (1994) 1.64
Sunlight exposure as risk factor for intraocular malignant melanoma. N Engl J Med (1985) 1.64
The dysplastic nevus syndrome: our definition. Am J Dermatopathol (1982) 1.63
A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion Group. Ann Intern Med (1996) 1.62
Incidence of cutaneous melanoma among non-Hispanic whites, Hispanics, Asians, and blacks: an analysis of california cancer registry data, 1988-93. Cancer Causes Control (1997) 1.61
Biology of tumor progression in human melanocytes. Lab Invest (1987) 1.61
Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst (1999) 1.61
Anal cytology as a screening tool for anal squamous intraepithelial lesions. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.60
The kin-cohort study for estimating penetrance. Am J Epidemiol (1998) 1.60
Multiple births and risk of epithelial ovarian cancer. J Natl Cancer Inst (2000) 1.59
Melanoma of unknown primary site: presentation, treatment, and prognosis--a single institution study. University of Pennsylvania Pigmented Lesion Study Group. Cancer (1997) 1.57
Factors influencing the age at natural menopause. J Chronic Dis (1987) 1.57
Fine needle aspiration in the diagnosis of metastatic melanoma. J Am Acad Dermatol (2000) 1.56
Action spectrum for retinal injury from near-ultraviolet radiation in the aphakic monkey. Am J Ophthalmol (1982) 1.56
Occupational risks of bladder cancer in the United States: I. White men. J Natl Cancer Inst (1989) 1.55
A study of 'crisis cards' in a community psychiatric service. Acta Psychiatr Scand (1999) 1.55
Histopathologic diagnosis of dysplastic nevi: concordance among pathologists convened by the World Health Organization Melanoma Programme. Hum Pathol (1991) 1.54
Colposcopic appearance of anal squamous intraepithelial lesions: relationship to histopathology. Dis Colon Rectum (1997) 1.52
High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med (1985) 1.51
A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N Engl J Med (1977) 1.51
The biologic forms of malignant melanoma. Hum Pathol (1986) 1.51
Epidemiology of bladder cancer. Hematol Oncol Clin North Am (1992) 1.50
Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma. Am J Pathol (1998) 1.50
Primary malignant melanoma of the urinary bladder. Cancer (1976) 1.48
99mTc-human serum albumin: an effective radiotracer for identifying sentinel lymph nodes in melanoma. J Nucl Med (1999) 1.46
Collection of buccal cell DNA using treated cards. Cancer Epidemiol Biomarkers Prev (2000) 1.46
Mortality and cancer incidence of aircraft maintenance workers exposed to trichloroethylene and other organic solvents and chemicals: extended follow up. Occup Environ Med (1998) 1.46
Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.46
Early melanoma. Histologic terms. Am J Dermatopathol (1991) 1.43